Table 3.
Genes overexpressed in macrodissected gastric cancer at feature selection P < 10-6
| Gene | FC1 | Gene | FC |
|---|---|---|---|
| LY6E | 24.42 | SRM | 6.7 |
| IL8 | 22.7 | NGLY1 | 6.7 |
| CA12 | 20.0 | RHOB | 6.3 |
| SBNO2 | 19.2 | ACTN1 | 5.9 |
| UBE2S | 17.2 | LOXL2 | 5.9 |
| CYR61 | 17.2 | COL5A2 | 5.9 |
| ANGPT2 | 15.9 | TRIM28 | 5.6 |
| COL6A2 | 14.3 | 218982_s_at | 5.6 |
| BOP1 | 13.2 | C7orf44 | 5.3 |
| COL1A1 | 13.2 | UBE2C | 5.3 |
| LPL | 13.0 | CEP76 | 5.3 |
| MFGE8 | 12.8 | BIRC5 | 5.3 |
| APOE | 12.2 | PNO1 | 5.0 |
| G6PC3 | 10.9 | FSTL1 | 5.0 |
| 215900_at | 10.3 | GRINA | 4.8 |
| NUP62 | 10.0 | MRTO4 | 4.8 |
| MRPL4 | 10.0 | STC1 | 4.8 |
| GNL3L | 10.0 | MRPL12 | 4.5 |
| MCAM | 9.1 | FKBP1A | 4.5 |
| PDLIM7 | 9.1 | IFI30 | 4.5 |
| 216472_at | 9.1 | KPNA6 | 4.3 |
| ACTN1 | 9.1 | 216532_x_at | 4.3 |
| BYSL | 9.1 | CENPI | 4.2 |
| GNAI2 | 8.3 | PPM1G | 4.2 |
| NCAPH2 | 8.3 | ICT1 | 3.7 |
| CD14 | 8.3 | SFRS14 | 3.6 |
| EXOSC4 | 8.3 | CTPS | 3.6 |
| OBFC2B | 8.3 | IMP4 | 3.3 |
| PPP1R15A | 7.7 | UBE2G2 | 3.2 |
| COL1A2 | 7.7 | ISG20L2 | 3.2 |
| GPX1 | 7.7 | EIF4A1 | 3.1 |
| MIF | 7.7 | HDGF | 2.6 |
| NME1 | 7.1 | PSMD14 2.6 | |
| PPIL2 | 7.1 | 220856_x_at | 2.4 |
| CCDC85B | 7.1 | CNOT3 | 2.4 |
| SPARC | 6.7 | GLT25D1 | 2.0 |
| C8orf55 | 6.7 |
1fold change, defined by the expression ratio of cancer to normal (= cancer/normal)
2All these genes had false discovery rate <0.001.